Clinical Trial Update: Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

This release reports results from a completed Phase 2 trial evaluating dose-reduced allogeneic stem cell transplantation after autologous high-dose chemotherapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Multiple Myeloma, Stem Cell Transplantation | Phase 2 | Status: COMPLETED